Bristol-Myers Squibb Company (NYSE:BMY) is projected to declare fiscal first quarter financial results right before the stock market’s official open on April 27, 2017. The stock added about 17.7 percent in price since last results when it was at $49.55 a share. Based on the most relevant past-periods data, there is an 53.57 percent probability for this firm’s share price to go down following next quarterly results. Earnings reaction history tells us that the equity price moved down 15 times out of last 28 reported quarters. It has beaten earnings-per-share estimates 91% of the time in its last 12 earnings reports. It fell short of earnings estimates on 1 occasions, and it has met expectations 0 time.
Here’s how traders responded to BMY earnings announcements over the past few quarters.
Bristol-Myers Squibb Company (BMY) Earnings Surprises & Reaction
Given its history, the average earnings announcement surprise was 7.26 percent over the past four quarters. Back on January 26, 2017, it posted earnings per-share earnings at $0.63 which missed the consensus $0.66 projection (negative surprise of-4.55%). For the quarter, revenue came in at 5.24B versus consensus estimate of 5.12B. The stock dropped -5.51 percent the session following the earnings reports were released, and on 7th day price change was 0 percent.
On October 27, 2016, it reported earnings at $0.77 a share compared with the consensus estimate of $0.65 per share (positive surprise of 18.46%). Revenue of 4.92B for that quarter was above the $4.8B analysts had expected. The stock climbed 5.42% the day following the earnings announcement, and on 7th day price change was 2.6%.
On July 28, 2016, it recorded $0.69 a share in earnings which topped the consensus estimate of $0.67 (positive surprise of 2.99%). Revenue for the quarter was $4.87B while analysts called for revenues to be $4.65B. The stock dropped -2.36% the day following the earnings data was made public, and on 7th day price change was -2.19%.
On April 28, 2016, it announced earnings per share at $0.74 versus the consensus estimate of $0.66 per share (positive surprise of 12.12%). That came on revenues of $4.39B for that period. Analysts had expected $4.25B in revenue.
Bristol-Myers Squibb Company Earnings Estimates
As Q1 earnings announcement date approaches, Wall Street is expecting earnings per share of $0.75. The analysts’ present consensus range is $0.66-$0.8 for EPS. The market consensus range for revenue is between $4.55B and $4.92B, with an average of $4.74B.
Bristol-Myers Squibb Company (NYSE:BMY) last ended at $56.93, sending the company’s market cap near $95.23B. The consensus 12-month price target from analysts covering the stock is $55.46. The share price has declined -25.18% from its top level in 52 weeks and advanced -1.94% this year. It recently traded in a range of $56.86-$58.3 at a volume of 11608308 shares. The recent trading ended with the price nearly -0.07 lower for the last 5 trading days, rebounding 23.73% from its 52-week low.